JAMA Cardiology published a clinical update in Cardiology on 01 Mar 2026. The item focuses on Cardiovascular-Kidney-Metabolic Medication Eligibility. Review the original article for the full source wording and details.
This cohort study evaluates eligibility for cardiovascular-kidney-metabolic medications in Europe and the US.